Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $289,332 - $307,908
-5,400 Reduced 58.7%
3,800 $213,000
Q1 2024

May 15, 2024

SELL
$42.56 - $59.82 $314,944 - $442,668
-7,400 Reduced 44.58%
9,200 $519,000
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $891,386 - $1.29 Million
-27,700 Reduced 62.53%
16,600 $745,000
Q3 2023

Nov 15, 2023

SELL
$44.2 - $50.2 $1.37 Million - $1.56 Million
-31,100 Reduced 41.25%
44,300 $2.02 Million
Q2 2023

Aug 23, 2023

BUY
$31.86 - $67.26 $1.51 Million - $3.19 Million
47,500 Added 170.25%
75,400 $3.27 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $1.27 Million - $2.07 Million
27,900 New
27,900 $1.8 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $95,920 - $125,455
-1,100 Reduced 29.73%
2,600 $276,000
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $197,799 - $261,429
-2,100 Reduced 36.21%
3,700 $410,000
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $1.73 Million - $2.02 Million
-14,500 Reduced 71.43%
5,800 $745,000
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $971,613 - $1.27 Million
8,900 Added 78.07%
20,300 $2.73 Million
Q2 2021

Aug 06, 2021

SELL
$100.34 - $115.69 $90,306 - $104,121
-900 Reduced 7.32%
11,400 $1.24 Million
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $761,325 - $939,525
7,500 Added 156.25%
12,300 $1.27 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $334,932 - $410,904
-3,900 Reduced 44.83%
4,800 $495,000
Q3 2020

Nov 13, 2020

BUY
$72.74 - $92.5 $378,248 - $481,000
5,200 Added 148.57%
8,700 $741,000
Q2 2020

Aug 13, 2020

BUY
$48.02 - $79.04 $168,070 - $276,640
3,500 New
3,500 $252,000
Q3 2019

Nov 14, 2019

SELL
$47.45 - $58.05 $716,495 - $876,555
-15,100 Closed
0 $0
Q2 2019

Aug 20, 2019

SELL
$39.26 - $54.21 $243,412 - $336,102
-6,200 Reduced 29.11%
15,100 $819,000
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $635,592 - $935,496
21,300 New
21,300 $865,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.